Lobbying Spend
—
Filings
32
Firms Hired
1
Active Period
2019–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Patients Deserve Price Tags Act
2026 · second_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
HCR: S. 2355 Patients Deserve Price Tags Act provisions related to drug price transparency and patient transparency tools; Department of Labors Notice of Proposed Rulemaking, Improving Transparency Into Pharmacy Benefit Manager Fee Disclosure (RIN 1210-AB37).
Client expense: — · Firm income: $10,000
Matched citations: S. 2355
Ensuring Access to Lower-Cost Medicines for Seniors Act of 2026.
2026 · first_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 8143 Ensuring Access to Lower Cost Medicines for Seniors Act of 2026; Public Law 119-75 - The Consolidated Appropriations Act, provisions regulating pharmacy benefit manager practices.
Client expense: — · Firm income: $10,000
Matched citations: H.R. 8143
Patients Deserve Price Tags Act
2026 · first_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
S. 2355 Patients Deserve Price Tags Act provisions related to drug price transparency and patient transparency tools; Department of Labors Notice of Proposed Rulemaking, Improving Transparency Into Pharmacy Benefit Manager Fee Disclosure (RIN 1210-AB37).
Client expense: — · Firm income: $10,000
Matched citations: S. 2355
H.R. 2214 - DRUG Act
Client expense: — · Firm income: $10,000
Matched citations: H.R. 2214
Bipartisan Health Care Act
2025 · fourth_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
S. 891 - The Bipartisan Health Care Act
Client expense: — · Firm income: $10,000
Matched citations: S. 891
H.R. 2214 - DRUG Act
Client expense: — · Firm income: $10,000
Matched citations: H.R. 2214
Bipartisan Health Care Act
2025 · third_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
S. 891 - The Bipartisan Health Care Act
Client expense: — · Firm income: $10,000
Matched citations: S. 891
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
2025 · second_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 2214 - DRUG Act; H.R. 1 - The One Big Beautiful Bill Act
Client expense: — · Firm income: $10,000
Matched citations: H.R. 1
H.R. 2214 - DRUG Act; H.R. 1 - The One Big Beautiful Bill Act
Client expense: — · Firm income: $10,000
Matched citations: H.R. 2214
Bipartisan Health Care Act
2025 · second_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
S. 891 - The Bipartisan Health Care Act
Client expense: — · Firm income: $10,000
Matched citations: S. 891
H.R. 2214 - DRUG Act
Client expense: — · Firm income: $10,000
Matched citations: H.R. 2214
Bipartisan Health Care Act
2025 · first_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
S. 891 - The Bipartisan Health Care Act
Client expense: — · Firm income: $10,000
Matched citations: S. 891
To require the Secretary of Health and Human Services to conduct a study on pharmacy benefit manager audit practices.
2024 · fourth_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H. R. 10050, Pharmacist Audit & Compensation Transparency Act; S. 2305, The Biosimilar Red Tape Elimination Act; H.R. 10445, Further Continuing Appropriation and Disaster Relief Supplemental Appropriations Act of 2025
Client expense: — · Firm income: $10,000
Matched citations: H. R. 10050
Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025
2024 · fourth_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 9096 - Pharmacists Fight Back Act; H.R. 10445, Further Continuing Appropriation and Disaster Relief Supplemental Appropriations Act of 2025
Client expense: — · Firm income: $10,000
Matched citations: H.R. 10445
Further Continuing Appropriations and Disaster Relief Supplemental Appropriations Act, 2025
2024 · fourth_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H. R. 10050, Pharmacist Audit & Compensation Transparency Act; S. 2305, The Biosimilar Red Tape Elimination Act; H.R. 10445, Further Continuing Appropriation and Disaster Relief Supplemental Appropriations Act of 2025
Client expense: — · Firm income: $10,000
Matched citations: H.R. 10445
Pharmacists Fight Back Act
2024 · fourth_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H.R. 9096 - Pharmacists Fight Back Act; H.R. 10445, Further Continuing Appropriation and Disaster Relief Supplemental Appropriations Act of 2025
Client expense: — · Firm income: $10,000
Matched citations: H.R. 9096
Biosimilar Red Tape Elimination Act
2024 · fourth_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
H. R. 10050, Pharmacist Audit & Compensation Transparency Act; S. 2305, The Biosimilar Red Tape Elimination Act; H.R. 10445, Further Continuing Appropriation and Disaster Relief Supplemental Appropriations Act of 2025
Client expense: — · Firm income: $10,000
Matched citations: S. 2305
Lower Costs, More Transparency Act
2024 · third_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
S. 1339 - Pharmacy Benefit Manager Reform Act; H.R. 5378 -Lower Costs, More Transparency Act; S. 1542/H.R. 6283 -The Delinking Revenue from Unfair Gouging (DRUG) Act; S. 127 - Pharmacy Benefit Manager Transparency Act of 2023.
Client expense: — · Firm income: $10,000
Matched citations: H.R. 5378
Seniors’ Access to Critical Medications Act of 2024
2024 · third_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
S. 2973-Modernizing and Ensuring PBM Accountability Act; S. 3430 - Better Mental Healthcare, Lower Cost Drugs & Extenders Act (provisions related to PBMs and pharmacy contracting); H.R. 5526 - Seniors Access to Critical Medications Act of 2023; H.R. 7623 - Telehealth Modernization Act of 2024
Client expense: — · Firm income: $10,000
Matched citations: H.R. 5526
S. 1339 - Pharmacy Benefit Manager Reform Act; H.R. 5378 -Lower Costs, More Transparency Act; S. 1542/H.R. 6283 -The Delinking Revenue from Unfair Gouging (DRUG) Act; S. 127 - Pharmacy Benefit Manager Transparency Act of 2023.
Client expense: — · Firm income: $10,000
Matched citations: H.R. 6283
Telehealth Modernization Act of 2024
2024 · third_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
S. 2973-Modernizing and Ensuring PBM Accountability Act; S. 3430 - Better Mental Healthcare, Lower Cost Drugs & Extenders Act (provisions related to PBMs and pharmacy contracting); H.R. 5526 - Seniors Access to Critical Medications Act of 2023; H.R. 7623 - Telehealth Modernization Act of 2024
Client expense: — · Firm income: $10,000
Matched citations: H.R. 7623
Pharmacy Benefit Manager Transparency Act of 2023
2024 · third_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
S. 1339 - Pharmacy Benefit Manager Reform Act; H.R. 5378 -Lower Costs, More Transparency Act; S. 1542/H.R. 6283 -The Delinking Revenue from Unfair Gouging (DRUG) Act; S. 127 - Pharmacy Benefit Manager Transparency Act of 2023.
Client expense: — · Firm income: $10,000
Matched citations: S. 127
Pharmacy Benefit Manager Reform Act
2024 · third_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
S. 1339 - Pharmacy Benefit Manager Reform Act; H.R. 5378 -Lower Costs, More Transparency Act; S. 1542/H.R. 6283 -The Delinking Revenue from Unfair Gouging (DRUG) Act; S. 127 - Pharmacy Benefit Manager Transparency Act of 2023.
Client expense: — · Firm income: $10,000
Matched citations: S. 1339
S. 1339 - Pharmacy Benefit Manager Reform Act; H.R. 5378 -Lower Costs, More Transparency Act; S. 1542/H.R. 6283 -The Delinking Revenue from Unfair Gouging (DRUG) Act; S. 127 - Pharmacy Benefit Manager Transparency Act of 2023.
Client expense: — · Firm income: $10,000
Matched citations: S. 1542
Modernizing and Ensuring PBM Accountability Act
2024 · third_quarter · Firm: HOOPER, LUNDY & BOOKMAN, P.C.
S. 2973-Modernizing and Ensuring PBM Accountability Act; S. 3430 - Better Mental Healthcare, Lower Cost Drugs & Extenders Act (provisions related to PBMs and pharmacy contracting); H.R. 5526 - Seniors Access to Critical Medications Act of 2023; H.R. 7623 - Telehealth Modernization Act of 2024
Client expense: — · Firm income: $10,000
Matched citations: S. 2973
Source: Senate LDA